2003
DOI: 10.1016/j.brainres.2003.08.050
|View full text |Cite
|
Sign up to set email alerts
|

Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
24
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 44 publications
3
24
0
Order By: Relevance
“…There was a significant decrease of approximately 20% in V1aR binding in the CeA after chronic PCP treatment (t-test, t ¼ 4.00, df ¼ 9, po0.003). As first reported by Tanaka et al (2003), following chronic PCP treatment, the binding of the V1aR specific ligand in LS was decreased by 58% following chronic PCP treatment (t-test, t ¼ 4.03, df ¼ 12, po0.002).…”
Section: Oxytocinergic and Vasopressinergic Marker Mrna Expression Insupporting
confidence: 73%
See 3 more Smart Citations
“…There was a significant decrease of approximately 20% in V1aR binding in the CeA after chronic PCP treatment (t-test, t ¼ 4.00, df ¼ 9, po0.003). As first reported by Tanaka et al (2003), following chronic PCP treatment, the binding of the V1aR specific ligand in LS was decreased by 58% following chronic PCP treatment (t-test, t ¼ 4.03, df ¼ 12, po0.002).…”
Section: Oxytocinergic and Vasopressinergic Marker Mrna Expression Insupporting
confidence: 73%
“…Brattleboro rats, a rat naturally lacking the ability to synthesize functional AVP, also exhibit PPI deficits (Feifel and Priebe, 2001). Thus, the successful treatment of sensorimotor gating disturbances with a neuropeptide along with the V1aR binding results of Tanaka et al (2003) are significant because they reaffirm the distinct possibility that, in animal models of schizophrenia, neuropeptides are altered by many different pharmacological and experiential manipulations purported to model schizophrenogenic insults. Furthermore, it predicts the potential efficacy of central-acting AVP or OT analogues as potential schizophrenia treatments.…”
Section: Introductionmentioning
confidence: 81%
See 2 more Smart Citations
“…Vasopressin in species such as the prairie vole, is a potent mediator of a variety of social behaviors (Witt et al, 1990, Young et al, 1997, Cho et al, 1999, Bales and Carter, 2003. In addition, vasopressin has been implicated in the social deficits in rats following repeated phencyclidine administration (Tanaka et al, 2003). How the present data integrate with the data from Tanaka and colleagues remains unclear.…”
Section: Discussionmentioning
confidence: 61%